Plasmodicidal effect of desferrioxamine B in human vivax or falciparum malaria from Thailand
- 30 September 1992
- journal article
- clinical trial
- Published by Elsevier in Acta Tropica
- Vol. 52 (1) , 59-67
- https://doi.org/10.1016/0001-706x(92)90007-k
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of Iron Chelation Therapy on Recovery from Deep Coma in Children with Cerebral MalariaNew England Journal of Medicine, 1992
- Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malariaThe Lancet, 1992
- Iron chelation with desferrioxamine B in adults with asymptomatic Plasmodium falciparum parasitemia [see comments]Blood, 1992
- Inhibition of Plasmodium falciparum growth by a synthetic iron chelatorTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- The epidemiology of drug-resistant malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Human Cerebral Malaria *The American Journal of Tropical Medicine and Hygiene, 1988
- TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIAThe Lancet, 1985
- Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferationBlood, 1984
- TREATMENT OF PLASMODIUM VIVAX MALARIA OF FOREIGN ORIGINArchives of internal medicine (1960), 1947
- CHLOROQUINE FOR TREATMENT OF ACUTE ATTACKS OF VIVAX MALARIAJAMA, 1946